Previous 10 | Next 10 |
Lantheus Holdings Inc. (NASDAQ:LNTH) traded today at a new 52-week high of $24.85. This new high was reached on below average trading volume as 371,000 shares traded hands, while the average 30-day volume is approximately 940,000 shares. In the past 52 weeks, shares of Lantheus Holdings ...
Shares of Lantheus Holdings (NASDAQ: LNTH) were soaring 17.1% as of 11:01 a.m. EDT on Thursday. The big jump came after the company announced that the Food and Drug Administration had approved Pylarify, an imaging agent used to identify prostate cancer. Today's significant gain ...
Vertex Energy (VTNR) +98% on deal for Shell's Mobile refinery.Moxian (MOXC) +37%.1847 Goedeker (GOED) +22%.SOS Limited (SOS) +14%.Bit Digital (BTBT) +13%.Vir Biotechnology (VIR) +9% as GSK/Vir COVID-19 biologic wins FDA Emergency Use Authorization.LAIX (LAIX) +12% on Q1 results...
Lantheus Holdings (LNTH) has climbed ~21.0% in the premarket after announcing the FDA approval for PYLARIFY in the identification of suspected metastasis or recurrence of prostate cancer.PYLARIFY is an F 18-labeled prostate-specific membrane antigen ((PSMA)) targeted posit...
PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U.S. by year end Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors enter next week prepped for more volatility with risk assets after the cryptocurrency plunge. The negative vib...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced today ...
Lantheus Holdings, Inc. (LNTH) Q1 2021 Results Earnings Conference Call May 04, 2021, 08:00 AM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer Conferen...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...